A STUDY OF ANTI-INFLAMMATORY AND ANTI-VIRALACTIVITY OF POLYHERBAL FORMULATION “LIVPRO®” IN HEPATITIS CPATIENTS
To investigate the safety and efficacy (anti-inflammatory and anti-viral) of poly herbal formulation LivPro® tablets in the management of patients with chronic hepatitis C infection. A total of 112 patients were enrolled in study. Patient dosage for LivPro® was 2t.i.d (2 tablets 3 times a day) for six months. Clinical assessment of signs and symptoms were registered using the Clinical Evaluation Performa at enrollment and subsequently after every 30 days. Biochemical investigations of Alanine Aminotransferase (ALT) also known as Serum Glutamic Pyruvic Transaminase (SGPT), Aspartate Aminotransferase (AST) also known as Serum Glutamic Oxaloacetic Transaminase (SGOT), Gamma Glutamyl Transpeptidase (Gamma GT or GGT), Total Bilirubin and Alkaline Phosphatase (ALP) as of liver function tests were evaluated every month along with their Hepatitis C Serum Antigen (HCsAg) using Enzyme Linked Immunosorbent Assay (ELISA) method.